Responses
Regular and young investigator award abstracts
Clinical trials completed
274 Tumoral and peripheral immunophenotype of refractory vs relapse to PD-(L)1 blockade in patients with advanced non-small cell lung cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
